Fourth Dimension Wealth LLC Invests $63,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Fourth Dimension Wealth LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, HoldingsChannel reports. The firm purchased 125 shares of the healthcare conglomerate’s stock, valued at approximately $63,000.

Other hedge funds also recently modified their holdings of the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group in the 4th quarter valued at $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $28,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $30,000. Finally, Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group in the 4th quarter valued at $30,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Wall Street Zen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday. Hsbc Global Res downgraded shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday. Barclays reduced their price target on shares of UnitedHealth Group from $513.00 to $362.00 and set an “overweight” rating for the company in a report on Thursday, May 15th. Bank of America downgraded shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and reduced their price target for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Finally, Argus downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, April 21st. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $441.87.

UnitedHealth Group Stock Performance

NYSE UNH opened at $295.37 on Friday. The firm has a market cap of $267.94 billion, a price-to-earnings ratio of 19.06, a PEG ratio of 1.37 and a beta of 0.56. The company has a 50 day moving average of $452.40 and a 200-day moving average of $505.07. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the business posted $6.91 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.84%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 35.18%.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction dated Friday, May 16th. The stock was bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Kristen Gil acquired 3,700 shares of the firm’s stock in a transaction that occurred on Thursday, May 15th. The shares were purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the acquisition, the director now owns 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.